Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Madrid
Clinical trial register · Spain

Clinical Trials in Madrid, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 28 Madrid 26 Seville 13 Málaga 11 Valencia 10
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca183 Janssen Research & Development, LLC109 Merck Sharp & Dohme LLC106 Novartis Pharmaceuticals100 Hoffmann-La Roche92 Clear sponsor filter
Site location
Barcelona28 Madrid26 Seville13 Málaga11 Valencia10
All 60 locations
Target enrolment
to

Trials with a site in Madrid

26 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Not yet open
Novo Nordisk A/S
Phase 3
84
El Palmar, Barcelona, Madrid, Seville, Valencia
2026-10-09
Recruiting
Novo Nordisk A/S
Phase 3
450
Fuenlabrada, Almería, Castilleja de la Cuesta, Ferrol, Madrid, Santiago de Compostela, Seville
2026-08-12
Recruiting
Novo Nordisk A/S
Phase 2
300
Vic, Barcelona, Centelles (Barcelona), Madrid, Santander, Seville
2026-06-22
Recruiting
Novo Nordisk A/S
Phase 3
2,500
A Coruña, Antequera, Barcelona, Centelles (Barcelona), Girona, Madrid, Manresa, Málaga
2026-05-21
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Recruiting
Novo Nordisk A/S
Phase 3
300
Guadalajara, Pozuelo de Alarcón, Barcelona, Castilleja de la Cuesta, Lleida, Logroño, Madrid, Vitoria-Gasteiz
2026-05-05
Active, closed
Novo Nordisk A/S
Phase 3
606
Almería, Barcelona, León, Madrid, Málaga, Pozuelo de Alarcón, Seville
2026-04-21
Recruiting
Novo Nordisk A/S
Phase 3
400
A Coruña, Badalona, Ferrol, Madrid, Málaga, San Sebastián de Los Reyes (Madrid), Santander, Santiago de Compostela
2026-04-20
Recruiting
Novo Nordisk A/S
Phase 3
400
A Coruña, Badalona, Ferrol, Madrid, Málaga, San Sebastián de Los Reyes (Madrid), Santander, Santiago de Compostela
2026-04-13
Recruiting
Novo Nordisk A/S
Phase 3
332
Madrid, Santander
2025-12-18
Recruiting
Novo Nordisk A/S
Phase 1
30
Barcelona, Madrid, Málaga, Salamanca, Valencia
2025-10-23
Recruiting
Novo Nordisk A/S
Phase 2
200
Granada, Girona, El Palmar, Barcelona, Denia, Las Palmas de Gran Canaria, Madrid, Majadahonda
2025-06-30
Recruiting
Novo Nordisk A/S
Phase 2
200
Granada, El Palmar, Barcelona, Las Palmas de Gran Canaria, Madrid, Valencia
2025-06-27
By invitation
Novo Nordisk A/S
Not applicable
36,000
Madrid
2025-04-30
Recruiting
Novo Nordisk A/S
Phase 3
510
Barcelona, Madrid, Seville
2025-02-17
Recruiting
Novo Nordisk A/S
Phase 3
480
Barakaldo, Barcelona, Madrid
2025-01-10
Recruiting
Novo Nordisk A/S
Phase 2
465
Barcelona, Córdoba, Getafe, L'Hospitalet de Llobregat, Madrid, Seville, Valencia
2024-12-02
Active, closed
Novo Nordisk A/S
Phase 3
10,000
Badalona, Málaga, El Palmar, A Coruña, Alicante, Barcelona, Lleida, Madrid
2024-06-25
Active, closed
Novo Nordisk A/S
Phase 3
673
Castilleja de la Cuesta, Salamanca, Majadahonda, Madrid, Sanlúcar de Barrameda, Santiago de Compostela, Seville, Valencia
2024-04-01
By invitation
A Study to Evaluate Safety of Exposure to Wegovy During Pregnancy
NCT05872022Pregnancy, Obesity, Overweight
Novo Nordisk A/S
Observational
728
Madrid
2023-07-05
Active, closed
Novo Nordisk A/S
Phase 3
7,101
Fuenlabrada, Alzira, Antequera, Barcelona, Castilleja de la Cuesta, Córdoba, Las Palmas de Gran Canaria, Madrid
2023-03-01
Active, closed
A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A
NCT05685238Haemophilia A, Haemophilia A With Inhibitors
Novo Nordisk A/S
Phase 3
451
Barcelona, Esplugues Llobregat, Madrid, Málaga
2023-02-13
Active, closed
Novo Nordisk A/S
Phase 3
3,400
Pamplona, Barcelona, Castilleja de la Cuesta, León, Madrid, Seville
2022-11-01
Active, closed
Novo Nordisk A/S
Phase 3
153
El Palmar, Barcelona, Madrid, Málaga
2022-03-24
Active, closed
Research Study to Look at How Well the Drug Concizumab Works in Your Body if You Have Haemophilia Without Inhibitors
NCT04082429Haemophilia A Without Inhibitors, Haemophilia B Without Inhibitors
DrugConcizumab
Novo Nordisk A/S
Phase 3
156
Madrid, Málaga, Oviedo, Seville, Valencia
2019-11-13
Active, closed
Novo Nordisk A/S
Phase 3
134
Barcelona, Madrid, Málaga, Oviedo, Seville
2019-10-21
Rows per page Showing 1–26 of 26
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/madrid

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 26 of those studies with a site in Madrid that also match the filters currently applied.

How many clinical trials are recruiting in Madrid?

14 of the 26 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 9 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Madrid), 26 studies
PhaseStudiesRecruitingShare
Phase 319973.1%
Phase 24415.4%
Not applicable103.8%
Observational103.8%
Phase 1113.8%

Most active sponsors

Lead sponsors with the most studies (Madrid)
Lead sponsorStudiesRecruiting
Novo Nordisk A/S2614
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.